|
|
|
|
| LEADER |
01488nam a2200229 u 4500 |
| 001 |
EB002010923 |
| 003 |
EBX01000000000000001173822 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
220201 r ||| eng |
| 245 |
0 |
0 |
|a Esophageal Doppler ultrasound-based cardiac output monitoring for real-time therapeutic management of hospitalized patients
|h Elektronische Ressource
|b a review
|
| 260 |
|
|
|a Rockville, Maryland
|b Agency for Healthcare Research and Quality
|c January 16, 2007, 2007
|
| 300 |
|
|
|a 1 PDF file (ix, 120)
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 710 |
2 |
|
|a United States
|b Agency for Healthcare Research and Quality
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a Technology assessment
|
| 500 |
|
|
|a Title from PDF title page
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK258763
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a The Centers for Medicare & Medicaid Services (CMS) requested that AHRQ commission an evidence report to inform CMS of the evidence regarding ultrasound-based monitoring of cardiac output (Doppler). This is currently listed as a Category II procedure (clinical reliability and efficacy not proven), which is "considered experimental and should not be covered at this time". Accordingly, on May 9th 2006, AHRQ, in consultation with CMS and ECRI, issued a Statement of Work (SOW) contracting ECRI to prepare an evidence report on this topic
|